Marie‐françcoise Chesselet

Marie‐françcoise Chesselet's AcademicInfluence.com Rankings

Biology

#15990

Historical Rank

Neuroscience

#2164

Historical Rank

biology Degrees

Download Badge

Biology

Marie‐françcoise Chesselet's Degrees

Doctorate Medicine Université Paris Cité

Why Is Marie‐françcoise Chesselet Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Marie‐françcoise Chesselet's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease (2016) (2050)
Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons* (2003) (843)
Mitochondrial dysfunction and oxidative stress in Parkinson's disease (2013) (515)
Time course of early motor and neuropathological anomalies in a knock‐in mouse model of Huntington's disease with 140 CAG repeats (2003) (475)
Basal ganglia and movement disorders: an update (1996) (399)
Early and Progressive Sensorimotor Anomalies in Mice Overexpressing Wild-Type Human α-Synuclein (2004) (386)
Enhanced sensitivity to N‐methyl‐D‐aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease (1999) (373)
Synchronous Neuronal Activity Is a Signal for Axonal Sprouting after Cortical Lesions in the Adult (2002) (350)
Direct Regulation of Adult Brain Function by the Male-Specific Factor SRY (2006) (325)
Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. (2001) (317)
Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein. (2004) (262)
Comparative distribution of mRNAs for glutamic acid decatrboxylase, tyrosine hydroxylase, and tachykinins in the basal ganglia: An in situ hybridization study in the rodent brain (1987) (238)
Early Motor Dysfunction and Striosomal Distribution of Huntingtin Microaggregates in Huntington's Disease Knock-In Mice (2002) (226)
A Progressive Mouse Model of Parkinson’s Disease: The Thy1-aSyn (“Line 61”) Mice (2012) (225)
Expression of Mu opioid receptor mRNA in rat brain: An in situ hybridization study at the single cell level (1994) (213)
Animal models of Parkinson’s disease progression (2008) (211)
Behavioral and immunohistochemical effects of chronic intravenous and subcutaneous infusions of varying doses of rotenone (2004) (205)
Mouse models of Huntington's disease. (2002) (200)
Somatostatin regulates dopamine release in rat striatal slices and cat caudate nuclei (1983) (195)
Apoptosis in Huntington's disease (2003) (189)
Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein (2012) (187)
Behavioral and histopathological consequences of paraquat intoxication in mice: Effects of α‐synuclein over‐expression (2007) (185)
Bacterial Artificial Chromosome Transgenic Mice Expressing a Truncated Mutant Parkin Exhibit Age-Dependent Hypokinetic Motor Deficits, Dopaminergic Neuron Degeneration, and Accumulation of Proteinase K-Resistant α-Synuclein (2009) (182)
Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect (2004) (179)
Alpha-synuclein and transgenic mouse models (2004) (179)
Amygdalonigral pathway: An anterograde study in the rat with Phaseolus vulgaris leucoagglutinin (PHA‐L) (1990) (177)
In vivo alpha-synuclein overexpression in rodents: A useful model of Parkinson's disease? (2008) (173)
3,4-Dihydroxyphenylalanine Reverses the Motor Deficits in Pitx3-Deficient Aphakia Mice: Behavioral Characterization of a Novel Genetic Model of Parkinson's Disease (2005) (172)
Neurons express hemoglobin α‐ and β‐chains in rat and human brains (2009) (171)
Olfactory deficits in mice overexpressing human wildtype α‐synuclein (2008) (164)
Tissue-Specific Proteolysis of Huntingtin (htt) in Human Brain: Evidence of Enhanced Levels of N- and C-Terminal htt Fragments in Huntington's Disease Striatum (2001) (163)
Modelling of Parkinson's disease in mice (2011) (162)
Striatal neurons expressing somatostatin-like immunoreactivity: Evidence for a peptidergic interneuronal system in the cat (1986) (154)
Cortical lesions induce an increase in cell number and PSA‐NCAM expression in the subventricular zone of adult rats (1996) (153)
Neuronal differentiation of stem cells isolated from adult muscle (2002) (152)
Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human α‐synuclein (2011) (139)
Decrease in Striatal Enkephalin mRNA in Mouse Models of Huntington’s Disease (2000) (136)
Compartmental distribution of striatal cell bodies expressing [Met]enkephalin-like immunoreactivity. (1984) (135)
Animal models of the non-motor features of Parkinson's disease (2012) (135)
Morphine and δ-opiate agonists locally stimulate in vivo dopamine release in cat caudate nucleus (1981) (128)
Genetic mouse models of Parkinson's disease The state of the art. (2010) (126)
Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia (2015) (120)
Adipose tissue dysfunction tracks disease progression in two Huntington's disease mouse models. (2009) (118)
High-resolution in situ hybridization histochemistry. (1989) (116)
Messenger RNAs encoding glutamate-decar☐ylases are differentially affected by nigrostriatal lesions in subpopulations of striatal neurons (1992) (114)
Traumatic brain injury in adult rats causes progressive nigrostriatal dopaminergic cell loss and enhanced vulnerability to the pesticide paraquat. (2011) (113)
Early behavioral deficits in R6/2 mice suitable for use in preclinical drug testing (2005) (113)
Genetic mouse models of parkinsonism: Strengths and limitations (2005) (110)
Effects of nigrostriatal lesions on the levels of messenger RNAs encoding two isoforms of glutamate decarboxylase in the globus pallidus and entopeduncular nucleus of the rat (1992) (109)
Abnormal colonic motility in mice overexpressing human wild-type &agr;-synuclein (2008) (107)
The Etiopathogenesis of Parkinson Disease and Suggestions for Future Research. Part II (2007) (106)
Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington's disease (2012) (105)
A new enzyme marker for striatal compartmentalization: NADPH diaphorase activity in the caudate nucleus and putamen of the cat (1986) (104)
Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype α-synuclein (2006) (100)
Adult reserve stem cells and their potential for tissue engineering (2007) (99)
Variable effects of chronic subcutaneous administration of rotenone on striatal histology (2004) (99)
A de novo compound targeting α-synuclein improves deficits in models of Parkinson's disease. (2016) (96)
Energetic Dysfunction in Quinolinic Acid‐Lesioned Rat Striatum (1997) (88)
Cognitive deficits in a mouse model of pre‐manifest Parkinson’s disease (2012) (87)
A GCase Chaperone Improves Motor Function in a Mouse Model of Synucleinopathy (2014) (85)
Modulation of dopamine release in rat striatal slices by delta opiate agonists. (1982) (84)
Ziram Causes Dopaminergic Cell Damage by Inhibiting E1 Ligase of the Proteasome* (2008) (84)
Region specific mitochondrial impairment in mice with widespread overexpression of alpha-synuclein (2014) (83)
Mice overexpressing wild‐type human alpha‐synuclein display alterations in colonic myenteric ganglia and defecation (2012) (81)
Characterization of striatal neurons expressing high levels of glutamic acid decar☐ylase messenger RNA (1989) (80)
Strengths and limitations of genetic mouse models of Parkinson's disease. (2008) (78)
The Etiopathogenesis of Parkinson Disease and Suggestions for Future Research. Part I (2007) (75)
Preproenkephalin messenger RNA—containing neurons in striatum of patients with symptomatic and presymptomatic huntington's disease: An in situ hybridization study (1991) (72)
Migration and fate of newly born cells after focal cortical ischemia in adult rats (2005) (71)
Functional and molecular development of striatal fast‐spiking GABAergic interneurons and their cortical inputs (2005) (70)
Synaptogenesis and ultrastructural localization of the polysialylated neural cell adhesion molecule in the developing striatum (1999) (68)
A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions (2011) (67)
Motor and Somatosensory Deficits Following Uni- and Bilateral Lesions of the Cortex Induced by Aspiration or Thermocoagulation in the Adult Rat (1998) (66)
The use of transgenic and knock-in mice to study Huntington’s disease (2003) (64)
A role for striatal beta-adrenergic receptors in the regulation of dopamine release (1982) (64)
Effects of unilateral electrical stimulation of various thalamic nuclei on the release of dopamine from dendrites and nerve terminals of neurons of the two nigrostriatal dopaminergic pathways (1983) (63)
Neuronal NOS and cyclooxygenase-2 contribute to DNA damage in a mouse model of Parkinson disease. (2009) (61)
Human Neural Stem Cell Transplantation Rescues Functional Deficits in R6/2 and Q140 Huntington's Disease Mice (2017) (61)
Behavioral phenotypes and pharmacology in genetic mouse models of Parkinsonism (2006) (60)
Met-enkephalin-like and dynorphin-like immunoreactivities of the basal ganglia of the cat. (1983) (59)
Distribution of glutamic acid decarboxylase (Mr 67 000) in the basal ganglia of the rat: an immunohistochemical study with a selective cDNA-generated polyclonal antibody (1991) (58)
Paradoxical increase in striatal neuropeptide gene expression following ischemic lesions of the cerebral cortex. (1992) (55)
Animal Models of Neurological Disorders (2005) (55)
A Role for N-Methyl-D-Aspartate Receptors in the Regulation of Synaptogenesis and Expression of the Polysialylated Form of the Neural Cell Adhesion Molecule in the Developing Striatum (1998) (53)
Early induction of mRNA for calbindin-D28k and BDNF but not NT-3 in rat hippocampus after kainic acid treatment. (1997) (53)
Vascular changes in the subventricular zone after distal cortical lesions (2005) (52)
Dopaminergic Stimulation of Subthalamic Nucleus Elicits Oral Dyskinesia in Rats (1994) (52)
Involvement of the thalamus in the asymmetric effects of unilateral sensory stimuli on the two nigrostriatal dopaminergic pathways in the cat (1981) (51)
Nigrostriatal Lesions Alter Oral Dyskinesia and c-Fos Expression Induced by the Serotonin Agonist 1-(m-Chlorophenyl)piperazine in Adult Rats (2000) (49)
Local and distal effects induced by unilateral striatal application of opiates in the absence or in the presence of naloxone on the release of dopamine in both caudate nuclei and substantiae nigrae of the cat (1983) (49)
Regional distribution and regulation of preprosomatostatin messenger RNA in the striatum, as revealed by in situ hybridization histochemistry. (1989) (47)
Isolation and characterization of cells with neurogenic potential from adult skeletal muscle. (2004) (47)
Striatal atrophy and dendritic alterations in a knock-in mouse model of Huntington's disease (2012) (47)
Mechanisms of subventricular zone expansion after focal cortical ischemic injury (2005) (45)
Effects of quinolinic acid on messenger RNAs encoding somatostatin and glutamic acid decarboxylases in the striatum of adult rats (1992) (45)
Expression of GAD (Mr 67,000) and Its Messenger RNA in Basal Ganglia and Cerebral Cortex after Ischemic Cortical Lesions in Rats (1993) (42)
A Molecular Tweezer Ameliorates Motor Deficits in Mice Overexpressing α-Synuclein (2017) (42)
Effects of various opiates including specific delta and mu agonists on dopamine release from nigrostriatal dopaminergic neurons in vitro in the rat and in vivo in the cat. (1982) (41)
Expression of Glutamic Acid Decarboxylase mRNA in Striatum and Pallidum in an Animal Model of Tardive Dyskinesia (1995) (41)
Intranasal NAP (davunetide) decreases tau hyperphosphorylation and moderately improves behavioral deficits in mice overexpressing α-synuclein (2014) (40)
N-Methyl-d-aspartate receptor blockade affects polysialylated neural cell adhesion molecule expression and synaptic density during striatal development (1999) (39)
Sleep Dysfunction and EEG Alterations in Mice Overexpressing Alpha-Synuclein (2018) (39)
Regulation of μ‐Opioid Receptor mRNA in Rat Globus Pallidus: Effects of Enkephalin Increases Induced by Short‐ and Long‐Term Haloperidol Administration (1994) (38)
Effects of antioxidants on cancer prevention and neuromotor performance in Atm deficient mice. (2008) (37)
Vocalization deficits in mice over-expressing alpha-synuclein, a model of pre-manifest Parkinson's disease. (2014) (36)
Electrophysiological and Morphological Changes in Striatal Spiny Neurons in R 6 / 2 Huntington ’ s Disease Transgenic Mice (2001) (36)
Comparison of huntingtin proteolytic fragments in human lymphoblast cell lines and human brain (2002) (35)
Heterogeneous distribution of dopamine D2 receptor mRNA in the rat striatum: A quantitative analysis with in situ hybridization histochemistry (1991) (35)
Low dose rotenone treatment causes selective transcriptional activation of cell death related pathways in dopaminergic neurons in vivo (2009) (35)
Preprotachykinin messenger RNA detected by in situ hybridization in striatal neurons of the human brain (1987) (34)
Increased behavioral response to dopaminergic stimulation of the subthalamic nucleus after nigrostriatal lesions (2000) (34)
Context dependent neuroprotective properties of prion protein (PrP) (2009) (33)
Transgenic rodent models to study alpha-synuclein pathogenesis, with a focus on cognitive deficits. (2015) (33)
Regulation of glutamic acid decarboxylase gene expression in efferent neurons of the basal ganglia. (1993) (33)
Deuterium‐reinforced linoleic acid lowers lipid peroxidation and mitigates cognitive impairment in the Q140 knock in mouse model of Huntington's disease (2018) (32)
Evidence for behavioral benefits of early dietary supplementation with CoEnzymeQ10 in a slowly progressing mouse model of Huntington's disease (2012) (31)
Molecular Mechanisms of Neurodegenerative Diseases (2000) (29)
Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons (2014) (29)
Clozapine and haloperidol have differential effects on glutamic acid decarboxylase mRNA in the pallidal nuclei of the rat. (1992) (29)
Serotonin2C ligands exhibiting full negative and positive intrinsic activity elicit purposeless oral movements in rats: distinct effects of agonists and inverse agonists in a rat model of Parkinson's disease. (2013) (28)
The Basal Ganglia (2003) (28)
Development of striatal fast-spiking GABAergic interneurons. (2007) (28)
Effects of decreased dopamine transporter levels on nigrostriatal neurons and paraquat/maneb toxicity in mice (2017) (27)
Phenotype onset in Huntington’s disease knock‐in mice is correlated with the incomplete splicing of the mutant huntingtin gene (2019) (27)
In situ hybridization of mRNA for β-preprotachykinin and preprosomatostatin in adult rat dorsal root ganglia: comparison with immunocytochemical localization (1988) (27)
Analysis of striatal transcriptome in mice overexpressing human wild-type alpha-synuclein supports synaptic dysfunction and suggests mechanisms of neuroprotection for striatal neurons (2011) (26)
Chapter 8 – Techniques for Motor Assessment in Rodents (2015) (22)
Selective blockade of serotonin2C receptor enhances Fos expression specifically in the striatum and the subthalamic nucleus within the basal ganglia (2010) (22)
Chronic nicotine improves cognitive and social impairment in mice overexpressing wild type α-synuclein (2018) (21)
Effect of GABAA receptor stimulation in the subthalamic nucleus on motor deficits induced by nigrostriatal lesions in the rat (2005) (21)
Social Cognition Impairments in Mice Overexpressing Alpha-Synuclein Under the Thy1 Promoter, a Model of Pre-manifest Parkinson’s Disease (2015) (20)
Regional differences in substance P-like immunoreactivity in the striatum correlate with levels of pre-protachykinin mRNA (1989) (20)
Impaired Baroreflex Function in Mice Overexpressing Alpha-Synuclein (2013) (20)
Mouse models of cognitive deficits due to alpha-synuclein pathology. (2011) (19)
Increased m-CPP-induced oral dyskinesia after lesion of serotonergic neurons (2001) (19)
Development and anatomic localization of torsinA. (2004) (18)
In Situ Hybridization Histochemistry (1990) (17)
Endomorphin-1: Induction of Motor Behavior and Lack of Receptor Desensitization (2001) (16)
Decreased opsin mRNA and immunoreactivity in progressive rod-cone degeneration (prcd): cytochemical studies of early disease and degeneration. (1994) (16)
Huntington’s Disease: Neurodegeneration (2009) (15)
Morphology and compartmental location of cells exhibiting DNA damage after quinolinic acid injections into rat striatum (1999) (15)
Clozapine decreases enkephalin mRNA in rat striatum (1992) (15)
Heterogeneous distribution of cytochrome oxidase activity in the rat substantia nigra: correlation with tyrosine hydroxylase and dynorphin immunoreactivities (1990) (15)
The enhanced oral response to the 5-HT2 agonist Ro 60-0175 in parkinsonian rats involves the entopeduncular nucleus: electrophysiological correlates (2013) (15)
Morphine and delta-opiate agonists locally stimulate in vivo dopamine release in cat caudate nucleus. (1981) (14)
Genetic mouse models of Parkinsons disease (2010) (12)
Differential effects of chronic treatment with haloperidol and clozapine on the level of preprosomatostatin mRNA in the striatum, nucleus accumbens, and frontal cortex of the rat (1990) (11)
Mapping the Basal Ganglia (2000) (11)
Dopamine and Parkinson's disease: is the killer in the house? (2003) (11)
Anatomical localization and regulation of somatostatin gene expression in the basal ganglia and its clinical implications. (1995) (11)
Presynaptic regulation of striatal dopamine release: in vivo and in vitro studies. (1982) (11)
Striatal Dopamine Release In Vitro: A β‐Adrenoceptor‐Regulated Response Not Mediated Through Cyclic AMP (1982) (9)
Alpha-synuclein pathology, microgliosis, and parvalbumin neuron loss in the amygdala associated with enhanced fear in the Thy1-aSyn model of Parkinson's disease (2021) (9)
Transplantation of multipotent cells extracted from adult skeletal muscles into the subventricular zone of adult rats (2005) (8)
A structural defect in schizophrenia (2000) (8)
Modeling Nonmotor Symptoms of Parkinson’s Disease in Genetic Mouse Models (2009) (7)
Physiological and Pathophysiological Aspects of 5-HT2c Receptors in Basal Ganglia (2011) (7)
Metabolic correlates of lesion-specific plasticity: an in vivo imaging study (2004) (7)
Epidural Spinal Cord Stimulation Improves Motor Function in Rats With Chemically Induced Parkinsonism (2019) (6)
Dopamine control of gene expression in basal ganglia nuclei: striatal and nonstriatal mechanisms. (1998) (6)
Region-specific sprouting of crossed corticofugal fibers after unilateral cortical lesions in adult mice (2006) (6)
Effect of neurturin on multipotent cells isolated from the adult skeletal muscle. (2005) (6)
Serotonin 2 C ligands exhibiting full negative and positive intrinsic activity elicit purposeless oral movements in rats : distinct effects of agonists and inverse agonists in a rat model of Parkinson ’ s disease (2013) (5)
GABA in the thalamic motor nuclei modulates dopamine release from the two dopaminergic nigrostriatal pathways in the cat (2004) (5)
Mouse Models of Mental Illness and Neurological Disease (2012) (5)
The biological sciences section program at the 60th Annual Meeting of the Gerontological Society of America. (2005) (5)
Dopamine — GABA Interactions (2002) (5)
The distribution and regulation of mu opioid receptor mRNA in rat basal ganglia (1994) (5)
Behavioral Assessment of Genetic Mouse Models of Huntington’s Disease (2011) (4)
Glutamic acid decarboxylase gene expression in thalamic reticular neurons transplanted as a cell suspension in the adult thalamus. (1993) (4)
Animal models of neurological disorders (2011) (4)
Parkinson's disease models: From toxins to genes (2005) (4)
Carboxypeptidase H-like immunoreactivity in the striatum of cats and monkeys (1988) (3)
Animal Models of Parkinson's Disease to Aid Drug Discovery and Development (2008) (3)
CHAPTER B6 – Phenotypical Characterization of Genetic Mouse Models of Parkinson Disease (2005) (3)
Detection of DNA Damage in Tissue Sections by In Situ Nick Translation (2001) (3)
Seventeenth Annual Symposia on Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Other Movement Disorders (2003) (2)
Cognitive Dysfunction in Genetic Mouse Models of Parkinsonism (2011) (2)
Post-translation modifications of neural cell surface molecules. (1990) (2)
Transcriptional regulation of α-synuclein: insights from blood? (2009) (2)
Environmental Explorations of Parkinson's Disease Using Rodent Genetic Models (2008) (1)
Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington's disease (2012) (1)
Behavioral Genetics of the Mouse: Parkinson’s disease (2014) (1)
7 – High-Resolution in Situ Hybridization Histochemistry (1989) (1)
A vaccine for Parkinson's disease? (2006) (1)
A New Look at Animal Models of Neurological Disorders (2023) (0)
Mechanisms of Subthalamic Dysfunction in Parkinson’s Disease (2001) (0)
Energetic and morphological changes in striatal cultures exposed to the mitochondrial toxin methylmalonate (1996) (0)
3.122 A NOVEL SERIES OF HUMAN ALPHA-SYNUCLEIN BAC TRANSGENIC MOUSE MODELS TO DISSECT IN VIVO PATHOGENIC MECHANISMS IN PARKINSON'S DISEASE (PD) (2012) (0)
Contents Vol. 100, 2003 (2003) (0)
Axonal Sprouting in the Adult Brain: Mechanisms of Lesion-Specific Sprouting of the Corticostriatal Pathway in Adult Rats (2005) (0)
Subject Index Vol. 100, 2003 (2003) (0)
Editorial Board (2017) (0)
Plasticity of GAD Gene Expression in Animal Models of Movement Disorders (2017) (0)
A GCase Chaperone Improves Motor Function in a Mouse Model of Synucleinopathy (2014) (0)
Acknowledgement to reviewers (2000) (0)
Book Reviews (1808) (0)
A Progressive Mouse Model of Parkinson’s Disease: The Thy1-aSyn (“Line 61”) Mice (2012) (0)
S9.3 Autonomic dysfunction in mice overexpressing human wildtype alpha synuclein (2009) (0)
Editorial Board (2015) (0)
Acknowledgement to Reviewers (1994) (0)
Clinical research is the study of patients with diseases, disorders, syndromes, and maladies, studied to improve our collective understanding. In other words, scientists are looking for something. And hoping to find it. However, sometimes RLS finds you. (2012) (0)
P2.019 Dopamine transporter knock-down in mice results in loss of nigral dopaminergic neurons and alters the effects of pesticide exposure (2009) (0)
Editorial Board (2011) (0)
Editorial Board (2016) (0)
Tu1972 Mice Overexpressing Wild-Type Human Alpha-Synuclein Display Alterations in Colonic Myenteric Ganglia and Propulsive Colonic Motor Function (2012) (0)
Mo1992 Effect of Ghrelin Agonist, Anamorelin on Feeding, Meal Structure and Body Weight in Alpha-Synuclein Over-Expressing Mice (2013) (0)
Reply (1997) (0)
O.026 Mice over-expressing wild-type human alpha-synuclein as tools for therapeutic discovery in Parkinson's disease (2009) (0)
Curcumin modulation of molecular chaperones in amyloidogenic models of neurodegenerative diseases (2012) (0)
Preproenkephahn Messenger RNA-containing Neurons in Striatwn of Patients with Symptomatic and Presymptomatic Huntington ’ s Disease : An In Situ Hybridization Study (2004) (0)
Traumatic brain injury and dopaminergic degeneration: the long-term risks require greater attention (2011) (0)
Early Behavioral Phenotypes in Mouse Models of Huntington’s and Parkinson’s Diseases (2005) (0)
P5 - TARGETING FREE RADICALS: A VALID THERAPEUTIC APPROACH FOR HUNTINGTON’S DISEASE? (2014) (0)
Editorial Board (2016) (0)
A Molecular Tweezer Ameliorates Motor Deficits in Mice Overexpressing α-Synuclein (2017) (0)
Local stimulatory effects of opiates on the in vivo release of dopamine in the cat caudate nucleus (1981) (0)
Faculty Opinions recommendation of Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmission. (2008) (0)
Animal Models of Neurological Disorders (2012) (0)
Mitochondria-Targeted Cholesterol Oximes Increase Dopamine-Related Gene Expression and Behavior in Mice Over-Expressing Alpha-Synuclein, a Model of Pre-Manifest Parkinson’s Disease (2014) (0)
Evidence for Neuronal Dysfunction in a Mouse Model of Early Stages of Huntington’s Disease (2002) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Marie‐françcoise Chesselet?

Marie‐françcoise Chesselet is affiliated with the following schools:

University of Pennsylvania